AI Solutions for R&D Challenges in Life Sciences - with Ramesh Durvasula of Eli Lilly

episode

The AI in Business Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Trump Hits Panic Button; FBI Cover-Up Blown and Melania Says Too Much 21 min · 24 Sep 2026 · IHIP News

Pablo Torre's Latest Bombshell Report | Local Hour 39 min · 24 Sep 2026 · The Dan Le Batard Show

American Idol Murder Trial: The Mistress Takes The Stand “I Believe He Murdered His Wife” 37 min · 24 Sep 2026 · Amy Robach & T.J. Holmes Present

Stocks Drop, Oil Surges, Trump: No AI Guardrails with Xi, More 7 min · 24 Sep 2026 · Bloomberg News Now

NPR News: 09-24-2026 9AM EDT 5 min · 24 Sep 2026 · NPR News Now

9AM ET 09/24/2026 Newscast 3 min · 24 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded19 Sep 2023

Publishertechemergence.libsyn.com ↗

Handlerec:6021085

Show notes

Today's guest is Ramesh Durvasula, Senior Vice President of R&D IT at Eli Lilly. Ramesh joins Emerj Senior Editor Matthew DeMello on the program today to survey the biggest challenges in biotech research and how emerging capabilities, particularly in generative AI, are paving the way for a new future for the industry. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in